Evidence for the efficacy of causal treatment for diabetic neuropathy is limited and based on small patient cohorts
The agency did not identify evidence supporting effectiveness through the proposed subcutaneous route
Peter Attia is the founder of Attia Medical, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity and optimal performance
Proc Natl Acad Sci USA 119:e2204557119 Watanabe Y, Hamaguchi-Tsuru E, Morimoto N, Nishio Y, Yagyu K, Konishi Y, Tominaga M, Miyazaki J, Furuya M, Tominaga A (2004) IL-5-induced eosinophils suppress the growth of Leishmania amazonensis in vivo and kill promastigotes in vitro in response to either IL-4 or IFN-gamma
10.1186/s12885-023-11093-w 14